Drug Profile
Research programme: vasopressin receptor modulators - Astellas Pharma
Alternative Names: YM-222546Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Class Acetamides; Benzazepines; Small molecules
- Mechanism of Action Vasopressin 1 receptor antagonists; Vasopressin V2 receptor agonists; Vasopressin V2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes insipidus; Heart failure; Nocturia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-insipidus in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Nocturia in Japan
- 03 Apr 2009 No development reported - Preclinical for Congestive heart failure in Japan (PO)